Point of Care
Hope and controversy surround new CLIA-waiver promising wider use of 20-minute HIV testing
Read MorePosted by Clinical Lab Products | Apr 3, 2003 | Cancer, Miscellaneous |
Hope and controversy surround new CLIA-waiver promising wider use of 20-minute HIV testing
Read MorePosted by Clinical Lab Products | Mar 10, 2003 | Heart Disease, Miscellaneous |
Long-term low-intensity warfarin therapy found highly effective in preventing recurrent VTE A new study led by Paul M. Ridker, M.D. of Brigham and Women’s Hospital and Harvard Medical School, has found that long-term, low-intensity warfarin t
Read MorePosted by Clinical Lab Products | Jan 9, 2003 | Cancer, Miscellaneous |
Voluntary market withdrawal of at-risk frozen blood products initiated to prevent spread of WNV from affs
Read MorePosted by Clinical Lab Products | Jan 2, 2003 | Cancer, Miscellaneous |
FDA approves new agents for treatment of opioid abuse
Read MorePosted by Clinical Lab Products | Nov 30, 2002 | Sexually Transmitted Diseases |
FDA-cleared HIV bDNA test includes automation
Read More